Collaboration is key to progress in lung cancer advocacy – Lung Cancer Europe
Lung Cancer Europe shared a post on LinkedIn:
” ‘Collaboration is key to progress in lung cancer advocacy.”
That’s what Yvonne Diaz, Co-founder and Chair of Oncogene Cancer Research, told us ahead of our AGM in Berlin at the end of this week (11–12 April).
As a member of Lung Cancer Europe, Oncogene Cancer Research is joining other member organisations from across Europe for two days of shared learning, discussion and connection.
Yvonne says she’s ‘excited to connect with the incredible LuCE community, share insights, and work together to drive better outcomes for all.’
The agenda includes sessions on mental health, exercise, and updates from the LuCE community – plus a focused masterclass on how AI can support lung cancer patient advocacy.”
Oncogene Cancer Research shared this post, adding:
“We are looking forward to taking part in the Lung Cancer Europe AGM and meeting next week in Berlin. By working together across patient organisations we can achieve outcomes for our lung cancer community faster.
We are Stronger Together.”
More posts featuring Lung Cancer Europe and Oncogene Cancer Research.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023